A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF THE TRIPLE COMBINATION OF AMLODIPINE/LOSARTAN/ROSUVASTATIN IN PATIENTS WITH ESSENTIAL HYPERTENSION

被引：0
|
作者：
Lee, H. [1 ]
Park, S. [2 ]
机构：
[1] Seoul Natl Univ Hosp, Seoul, South Korea
[2] Samsung Hosp, Seoul, South Korea
来源：
JOURNAL OF HYPERTENSION | 2017年 / 35卷
关键词：
D O I：
10.1097/01.hjh.0000523533.01598.7c
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
PP.12.23
引用
收藏
页码：E193 / E193
页数：1
相关论文
共 50 条
  • [41] Erratum to: Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial
    Il Suk Sohn
    Chong-Jin Kim
    Byung-Hee Oh
    Taek-Jong Hong
    Chang-Gyu Park
    Byung-Soo Kim
    Woo-Baek Chung
    American Journal of Cardiovascular Drugs, 2016, 16 : 139 - 139
  • [42] Efficacy and Safety of Coadministered Ezetimibe-Rosuvastatin plus Telmisartan in South Korean Patients with Dyslipidemia and Hypertension: A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase III Trial
    Song, Zhao-Yan
    Kim, Moo-Hyun
    Lee, Han-Cheol
    Park, Sung-Ji
    Rhee, Moo-Yong
    Choi, Jong-Il
    Kim, Sang-Hyun
    Chae, In-Ho
    Hong, Young-Joon
    Lee, Nam-Ho
    Hwang, Gyo-Seung
    Hur, Seung-Ho
    Son, Jung-Woo
    Chae, Jei-Keon
    Kim, Hyo-Soo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)
  • [43] A randomized, double-blind study of losartan versus irbesartan in patients with mild-to-moderate essential hypertension
    Zeldin, RK
    Gazdick, L
    Kerns, DE
    DeLucca, PT
    Lyle, PA
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (10): : 1189 - 1189
  • [44] A phase III, open-label, multicenter study to evaluate the safety and efficacy of long-term triple combination therapy with azilsartan, amlodipine, and hydrochlorothiazide in patients with essential hypertension (vol 27, pg 125, 2017)
    Rakugi, H.
    Shimizu, K.
    Nishiyama, Y.
    BLOOD PRESSURE, 2018, 27 (03) : 184 - 184
  • [45] Efficacy and safety of fixed-dose losartan/hydrochlorothiazide/amlodipine combination versus losartan/hydrochlorothiazide combination in Japanese patients with essential hypertension
    Rakugi, Hiromi
    Tsuchihashi, Takuya
    Shimada, Kazuyuki
    Numaguchi, Hirotaka
    Nishida, Chisato
    Yamaguchi, Hiroya
    Shirakawa, Masayoshi
    Azuma, Kyoichi
    Fujita, Kenji P.
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2015, 37 (03) : 260 - 266
  • [46] Safety and efficacy of iloperidone in patients with psychotic disorders: A randomized, double-blind multicenter study
    Matkovits-Gupta, T
    Cucchiaro, J
    El-Bizri, H
    Fairweather, D
    Klonowski, E
    Lasser, R
    Nann-Vernotica, E
    Narurkar, M
    Pirrozi, C
    Waltrip, R
    Young, F
    Gharabawi, G
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 238 - 238
  • [47] A Multicenter, Double-Blind, Phase III Clinical Trial to Evaluate the Efficacy and Safety of a Cell and Gene Therapy in Knee Osteoarthritis Patients
    Kim, Myung-Ku
    Ha, Chul-Won
    In, Yong
    Cho, Sung-Do
    Choi, Eui-Sung
    Ha, Jeong-Ku
    Lee, Ju-Hong
    Yoo, Jae-Doo
    Bing, Seong-Il
    Choi, Choong-Hyeok
    Kyung, Hee-Soo
    Lee, Myung-Chul
    HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 2018, 29 (01) : 48 - 59
  • [48] A PHASE III, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF NEUCARDIN™ IN PATIENTS WITH CHRONIC HEART FAILURE
    Gao, Runlin
    Zhang, Jian
    Liu, Heping
    Wang, Lina
    Pang, Xiaohua
    Fu, Lu
    Meng, Fanbo
    Zhou, Mingdong
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 668 - 668
  • [49] Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study
    Watanabe, Shinichi
    Kishida, Hiroshi
    Okubo, Akihiro
    JOURNAL OF DERMATOLOGY, 2017, 44 (07): : 753 - 759
  • [50] Efficacy and safety of bisoprolol 5 mg plus amlodipine 5 mg in patients with hypertension uncontrolled on monotherapy with 5 mg of amlodipine, a phase III multicenter, randomized, double-blind, placebo-controlled clinical trial - the AMCOR study
    Jedrusik, Piotr
    Placha, Grzegorz
    Gaciong, Zbigniew
    AMCOR Trial Investigators
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (07) : 939 - 946
12345